Trademark: 98608117
Word
ADGLYSS
Status
Pending
Status Code
681
Status Date
Wednesday, August 28, 2024
Serial Number
98608117
Mark Type
4
Filing Date
Wednesday, June 19, 2024
Published for Opposition
Tuesday, October 1, 2024

Trademark Owner History

Classifications
5 Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

Trademark Events
Jun 19, 2024
New Application Entered
Jun 19, 2024
New Application Office Supplied Data Entered
Aug 27, 2024
Approved For Pub - Principal Register
Aug 27, 2024
Assigned To Examiner
Sep 11, 2024
Notification Of Notice Of Publication E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24